Clinical use of alpha-interferon in onco-hematology: conclusions and prospects
Bernasconi, C.
Haematologica 75(Suppl 4): 82-84
1990
ISSN/ISBN: 0390-6078 PMID: 2074058 Document Number: 366845
Document emailed within 1 workday
Related Documents
Pelicci, P.G.; Grignani, F. 1991: Molecular biology in onco-hematology Haematologica 76(Suppl 3): 11-18Lepage, E. 1989: Metaanalysis: methodology, biostatistic rules, application in onco-hematology Nouvelle Revue Francaise d'Hematologie 31(2): 89-91
Boiron, M. 1986: The therapy of acute myelogenous leukemia, a major challenge of onco-hematology Pathologie-Biologie 34(3): 153-156
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Trede, M.; Wendl, K.; Richter, A. 1998: Pancreatic carcinoma--conclusions and prospects Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115: 411-420
Rumiantsev, A.G.; Vladimirskaia, E.B. 1989: Prospects and ways of development of child hematology Gematologiia i Transfuziologiia 34(9): 3-8
Gavrilov, O.K. 1979: Successes and developmental prospects of molecular hematology and transfusion science Problemy Gematologii i Perelivaniia Krovi 24(9): 3-8
Clark-Kazak, C. 2012: Conclusions, reflections, and prospects for future research, policy, and programming New Directions for Child and Adolescent Development 2012(136): 93-98
Cooper, M.R. 1991: A review of the clinical studies of alpha-interferon in the management of multiple myeloma Seminars in Oncology 18(5 Suppl 7: 18-29
Pazdur, R.; Bready, B.; Moore, D.F. 1991: Clinical trials of fluorouracil with alpha-interferon in advanced colorectal carcinomas Seminars in Oncology 18(5 Suppl 7: 67-70
Carballido, J.; Alvarez-Mon, M.; Olivier, C.; Moltó, L. 1990: Immunotherapy of urothelial neoplasms. Experimental and clinical implications of alpha interferon Archivos Espanoles de Urologia 43(Suppl 2): 149-158
Privitera, G.; Auxilia, F.; Bosisio, C.; Castaldi, S.; Pagano, A. 1996: Application of clinical audit to the evaluation of prescription of interferon-alpha in a teaching hospital Epidemiologia E Prevenzione 20(1): 11-17
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364